ecancer

ASCO 2014 roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

2 Jun 2014

Cancer evasion of the immune system: the fundamentals

Prof Pedro Romero - Ludwig Institute for Cancer Research, Lausanne, Switzerland

20 May 2014

New antibody-drug conjugate shows early promise against all forms of melanoma

Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA

1 May 2014

Immunotherapy in melanoma

Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA

1 May 2014

Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC

1 May 2014

Promising advances in the treatment of lung cancer using MK-3475 as an immune checkpoint inhibitor

Dr Leena Gandhi - Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA

1 May 2014

Biomarker identifies melanoma patients who may respond to immunotherapy MK-3475

Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA

1 May 2014

New antibody-drug conjugate shows early promise against all forms of melanoma

Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA

16 Apr 2014

Biomarker development for ipilimumab and prostate GVAX treatment

Prof Tanja D. de Gruijl - VU University Medical Centre, Amsterdam, The Netherlands

26 Mar 2014

Toll like receptor 7 agonists for cancer immunotherapy

Prof Stefan Endres - Ludwig-Maximilians-Universität, Munich, Germany

25 Mar 2014

Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes

Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen, Denmark

25 Mar 2014

The 1st Immunotherapy of Cancer Conference (ITOC)

Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria

25 Mar 2014

More from ecancer